A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study

BACKGROUND: The concordance rate of human epidermal growth factor receptor 2 (HER2) status between core needle biopsy (CNB) and subsequent excisional biopsies of the same tumor varies from 81 to 96%, which may cause inappropriate neoadjuvant therapy that impair the potential benefit from HER2 target...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huimin, Xie, Peiling, Li, Zhuoying, Huang, Rong, Feng, Weiliang, Kong, Yanan, Xu, Feng, Zhao, Lin, Song, Qingkun, Li, Jing, Zhang, Baoning, Fan, Jinhu, Qiao, Youlin, Xie, Xiaoming, Zheng, Shan, He, Jianjun, Wang, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500005/
https://www.ncbi.nlm.nih.gov/pubmed/31054583
http://dx.doi.org/10.1186/s13000-019-0806-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500005/
https://www.ncbi.nlm.nih.gov/pubmed/31054583
http://dx.doi.org/10.1186/s13000-019-0806-4

Ejemplares similares